country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-N21582

Copy Link Print Information

Gitogenin 3-O-lycotetroside

Gitogenin 3-O-lycotetroside is a steroidal saponin derived from Allium victorialis var. platyphyllum, exhibiting cytotoxic inhibitory activity against cancer cells and being metabolized by human intestinal bacteria. Gitogenin 3-O-lycotetroside can be used in cancer research.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No.: 28591-01-7
Formule: C₅₀H₈₂O₂₃
Masse moléculaire:1051.17

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Gitogenin 3-O-lycotetroside Chemical Structure

CAS No.: 28591-01-7

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- Cellular Effect
- In Vitro
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

Cellular Effect

Cell Line	Type	Value	Description	References
HepG2	IC50	17.9 μg/mL	Cytotoxicity against human hepatoblastoma HepG-2 cells assessed by MTT assay after 48 hrs of treatment. Cytotoxicity against human hepatoblastoma HepG-2 cells assessed by MTT assay after 48 hrs of treatment.	11235811
Vero	IC50	14.6 μg/mL	Cytotoxicity against monkey kidney Vero-P128 cells assessed by MTT assay after 48 hrs of treatment. Cytotoxicity against monkey kidney Vero-P128 cells assessed by MTT assay after 48 hrs of treatment.	11235811
P388	IC50	36.5 μg/mL	Cytotoxicity against mouse lymphoma leukemia P-388 cells assessed by MTT assay after 48 hrs of treatment. Cytotoxicity against mouse lymphoma leukemia P-388 cells assessed by MTT assay after 48 hrs of treatment.	11235811
L1210	IC50	6.5 μg/mL	Cytotoxicity against mouse lymphomatic leukemia L-1210 cells assessed by MTT assay after 48 hrs of treatment. Cytotoxicity against mouse lymphomatic leukemia L-1210 cells assessed by MTT assay after 48 hrs of treatment.	11235811

In Vitro

Gitogenin 3-O-lycotetroside (Serial dilutions; 48 h) exhibits potent cytotoxic activity in the range of 6.51-36.5 μg/mL across HepG-2, Vero-P128, P-388, and L-1210 cell lines, with the strongest potency observed against L-1210 cells (IC₅₀ = 6.5 μg/mL)^[1].
Incubation of gitogenin 3-O-lycotetroside (100 mg; 24 h) with human intestinal bacteria for 24 h at 37°C leads to the production of metabolites 3d and 3e, with the structure of 3e suggesting hydrolysis of the spiroketal ring E/F^[1].
Gitogenin 3-O-lycotetroside (2 mg; 24 h) is progressively degraded by human intestinal bacteria in a time-dependent manner, with metabolite 3e appearing at 6 h and metabolite 3d at 24 h^[1].
Gitogenin 3-O-lycotetroside (0.1-0.2 mg/mL; 24 h) reduces cell viability in HT-29 human colon cancer cells in a dose-dependent manner, with 68% inhibition observed at 0.2 mg/mL^[2].
Gitogenin 3-O-lycotetroside (0.01-0.2 mg/mL; 24 h) induces apoptotic morphological changes, including chromatin condensation and formation of apoptotic bodies, in HT-29 human colon cancer cells^[2].
Gitogenin 3-O-lycotetroside (0.01-0.2 mg/mL; 24 h) induces internucleosomal DNA fragmentation in HT-29 human colon cancer cells^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay^[2]

Cell Line:

HT-29
Concentration:

0.1, 0.2 mg/mL
Incubation Time:

24 h
Result:

Reduced cell viability by 9% at 0.1 mg/mL and 68% at 0.2 mg/mL.

Apoptosis Analysis^[2]

Cell Line:

HT-29
Concentration:

0.01, 0.1, 0.2 mg/mL
Incubation Time:

24 h
Result:

Induced apoptotic morphological changes, including chromatin condensation and formation of apoptotic bodies.

Chemical Information

CAS No. 28591-01-7
Masse moléculaire 1051.17
Formule C₅₀H₈₂O₂₃
SMILES

C[C@@]12[C@]3([H])[C@](O[C@]4(CC[C@H](CO4)C)[C@H]3C)([H])C[C@@]1([H])[C@@]5([H])[C@]([C@@]6([C@@](C[C@H]([C@@H](C6)O)O[C@@H]7O[C@@H]([C@@H]([C@@H]([C@H]7O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@@H]%10O[C@@H]([C@H]([C@@H]([C@H]%10O)O)O)CO)CO)([H])CC5)C)([H])CC2
Structure Classification
- Steroids
Initial Source
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Instruction de manipulation (2659 KB)

Références

[1]. Lee KT, et al. Constituents and the antitumor principle of Allium victorialis var. platyphyllum. Archives of pharmacal research. 2001 Feb;24(1):44-50.

[2]. Kim HJ, et al. Chemopreventive and Anticancer Activities of Allium victorialis var. platyphyllum Extracts. Journal of cancer prevention. 2014 Sep;19(3):179-86.

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Obtenir un devis En stock

Other size

Obtenir un devis